U.S. Vaccines Market All Sets For Continued Outperformance | GSK, Inovio Pharmaceuticals, Pfizer
Author : Pranita Y | Published On : 25 Apr 2024
Market Research Forecast added research publication document on Worldwide U.S. Vaccines Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide U.S. Vaccines Market. The study provides valuable market size data for historical (Volume** & Value) from 2019 to 2022 which is estimated and forecasted till 2030*. Some are the key & emerging players that are part of coverage and have being profiled are GSK plc. (U.K.), Sanofi (France), Pfizer Inc. (U.S.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Emergent BioSolutions, Inc. (U.S.), CSL Limited (Australia), Inovio Pharmaceuticals, Inc. (U.S.), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan).
Get free access to Sample Report in PDF Version along with Graphs and Figures @ https://marketresearchforecast.com/report/us-vaccines-market-516/sample-report?utm_source=OpenPR&utm_medium=Pranita
The U.S. Vaccines Market size was valued at USD 34.37 USD Billion in 2023 and is projected to reach USD 59.67 USD Billion by 2032, exhibiting a CAGR of 8.2 % during the forecast period.The increasing prevalence of infectious diseases, the rising demand for vaccines for both adults and children, and the government's focus on immunization programs are primary factors propelling market growth.The market's industry trends are analyzed in the latest research study. Industry trends, pricing analysis, patent analysis, conference and webinar materials, important stakeholders, and market purchasing behavior are all included in the latest research study.Strong government funding for vaccine development, expanding immunization programs in developed and emerging nations, and the launch of medicines that are still undergoing clinical trials are all factors contributing to the vaccine market's notable rise.
October 2023: Sanofi entered an agreement with Janssen Pharmaceuticals, Inc. to develop and commercialize a phase III vaccine product indicated against extraintestinal pathogenic E. coli.
March 2023: CSL Limited established a new state-of-the-art vaccine R&D center in Massachusetts.
October 2022: GSK plc. received approval from the U.S. FDA for its vaccine, Menveo, with single vial presentation for individuals suffering from invasive meningococcal disease.
Keep yourself up-to-date with latest market trends and changing dynamics due to COVID Impact and Economic Slowdown globally. Maintain a competitive edge by sizing up with available business opportunity in U.S. Vaccines Market various segments and emerging territory.
Influencing Market Trend
- Development of mRNA vaccines for various diseases
- Advancements in vaccine delivery systems
- Focus on personalized vaccines
- Increasing role of AI and machine learning in vaccine research.
Challenges:
- Stringent regulatory approvals
- Adverse events associated with vaccines
- Lack of awareness about the importance of vaccinations
Analysis by Type ( Live Attenuated, mRNA, Viral Vectors, Toxoid, and Others), by Route of Administration ( Parenteral and Oral), by Disease Indication ( Viral Diseases {Hepatitis, Influenza, Human Papillomavirus, Herpes Zoster, and Others}, and Bacterial Diseases {Meningococcal Disease, Pneumococcal Disease and Others}), by Age Group ( Pediatrics and Adults), by Distribution Channel ( Hospital & Retail Pharmacies, Government Suppliers, and Others) Forecast 2024-2031
Competitive landscape highlighting important parameters that players are gaining along with the Market Development/evolution
• % Market Share, Segment Revenue, Swot Analysis for each profiled company [GSK plc. (U.K.), Sanofi (France), Pfizer Inc. (U.S.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Emergent BioSolutions, Inc. (U.S.), CSL Limited (Australia), Inovio Pharmaceuticals, Inc. (U.S.), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan)]
• Business overview and Product/Service classification
• Product/Service Matrix [Players by Product/Service comparative analysis]
• Recent Developments (Technology advancement, Product Launch or Expansion plan, Manufacturing and R&D etc)
• Consumption, Capacity & Production by Players
Have Any Questions Regarding Global U.S. Vaccines Market Report, Ask Our Experts@ https://marketresearchforecast.com/report/us-vaccines-market-516/enquiry-before-buy?utm_source=OpenPR&utm_medium=Pranita
The regional analysis of Global U.S. Vaccines Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Whereas, owing to rising no. of research activities in countries such as China, India, and Japan, Asia Pacific region is also expected to exhibit higher growth rate the forecast period 2023-2030.
Table of Content
Chapter One: Industry Overview
Chapter Two: Major Segmentation (Classification, Application and etc.) Analysis
Chapter Three: Production Market Analysis
Chapter Four: Sales Market Analysis
Chapter Five: Consumption Market Analysis
Chapter Six: Production, Sales and Consumption Market Comparison Analysis
Chapter Seven: Major Manufacturers Production and Sales Market Comparison Analysis
Chapter Eight: Competition Analysis by Players
Chapter Nine: Marketing Channel Analysis
Chapter Ten: New Project Investment Feasibility Analysis
Chapter Eleven: Manufacturing Cost Analysis
Chapter Twelve: Industrial Chain, Sourcing Strategy and Downstream Buyers
Read Executive Summary and Detailed Index of full Research Study @ https://marketresearchforecast.com/reports/us-vaccines-market-516?utm_source=OpenPR&utm_medium=Pranita
Highlights of the Report
• The future prospects of the global U.S. Vaccines Market during the forecast period 2023-2030 are given in the report.
• The major developmental strategies integrated by the leading players to sustain a competitive market position in the market are included in the report.
• The emerging technologies that are driving the growth of the market are highlighted in the report.
• The market value of the segments that are leading the market and the sub-segments are mentioned in the report.
• The report studies the leading manufacturers and other players entering the global U.S. Vaccines Market.
Contact US:
Craig Francis (PR & Marketing Manager)
Market Research Forecast
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 201 565 3262, +44 161 818 8166
sales@advancemarketanalytics.com
Connect with us at
https://www.linkedin.com/company/advance-market-analytics
https://www.facebook.com/AMA-Research-Media-LLP-344722399585916
https://twitter.com/amareport
